Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   

CLINICAL MEASUREMENT - ANNOTATIONS

The Clinical Measurement Ontology (CMO), Measurement Methods Ontology (MMO), and Experimental Condition Ontology (XCO) are currently being developed at the Rat Genome Database. For more information about these vocabularies please see Shimoyama et al. Three ontologies to define phenotype measurement data. Front Genet. 2012;3:87. Epub 2012 May 28 or contact us (http://rgd.mcw.edu/contact/index.shtml).

Term:Toxoplasma gondii infection incidence/prevalence measurement
go back to main search page
Accession:CMO:0002027 term browser browse the term
Definition:Any measurement in which the number of individuals in a study population that display an infection with the parasite Toxoplasma gondii at a point in time or develop an infection with the parasite Toxoplasma gondii within a determined period of time are compared to the total number of individuals in the study population. Often expressed as a percentage but could be expressed as a ratio. Toxoplasma gondii is a sporozoan species that is an intracellular parasite in a variety of vertebrates and is the causative agent of toxoplasmosis.
Synonyms:related_synonym: toxoplasmosis incidence/prevalence measurement



show annotations for term's descendants           Sort by:
percentage of study population displaying Toxoplasma gondii brain cysts at a point in time term browser
Symbol Object Name Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Toxo1 Toxoplasma gondii resistance QTL 1 IDA RGD PMID:16407112 RGD:1578521 NCBI chr10:52,200,030...59,378,278 JBrowse link

Term paths to the root